Nuvation Bio Inc.
NUVB
$6.22
$0.121.97%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -62.84M | 5.40M | -36.59M | -55.79M | -59.01M |
| Total Depreciation and Amortization | 536.00K | 536.00K | 539.00K | 534.00K | 356.00K |
| Total Amortization of Deferred Charges | 350.00K | 321.00K | 327.00K | 317.00K | 18.00K |
| Total Other Non-Cash Items | 24.05M | 10.31M | 12.27M | 10.71M | 10.26M |
| Change in Net Operating Assets | -5.06M | -11.50M | -6.28M | -8.66M | 194.00K |
| Cash from Operations | -42.97M | 5.07M | -29.73M | -52.89M | -48.18M |
| Capital Expenditure | -254.00K | -48.00K | -89.00K | -12.00K | -181.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.25M | -43.59M | 87.17M | -96.61M | 55.06M |
| Cash from Investing | 5.99M | -43.64M | 87.08M | -96.62M | 54.88M |
| Total Debt Issued | 243.75M | -- | 11.20M | 0.00 | 198.90M |
| Total Debt Repaid | -59.71M | -864.00K | -11.62M | -68.00K | -166.00K |
| Issuance of Common Stock | 4.75M | 908.00K | 8.49M | 558.00K | 1.30M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.26M | -- | 0.00 | 11.00K | -6.61M |
| Cash from Financing | 170.53M | 44.00K | 8.06M | 501.00K | 193.42M |
| Foreign Exchange rate Adjustments | -338.00K | -172.00K | -224.00K | -64.00K | -128.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 133.21M | -38.70M | 65.19M | -149.07M | 199.99M |